SCHEMBL12307447

SCHEMBL12307447

CNC(=O)Nc1cc2n(n1)CCN2C(=O)c1ccncc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.36
▸ ENPP3 O14638 1/20 0.36
▸ ALPL P05186 1/20 0.36
▸ XIAP P98170 1/20 0.36
▸ NAMPT P43490 4/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ GRM5 P41594 2/20 0.36
▸ GAA P10253 1/20 0.35
▸ RECQL P46063 1/20 0.34
▸ LMNA P02545 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CYP3A4 P08684 4/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12307391 0.89 GRM5 (0.45) ALDH1A1MEN1KMT2AGRM5RECQL
SCHEMBL12307471 0.88 GRM5 (0.37) ALDH1A1NAMPTGRM5LMNA
SCHEMBL12307457 0.88 TP53 (0.36) ALDH1A1MEN1KMT2AGRM5LMNA
SCHEMBL12307461 0.87 GRM5 (0.44) ALDH1A1ENPP3ALPLXIAPGRM5
SCHEMBL12307445 0.86 STAT3 (0.45) ALDH1A1LMNACYP3A4HSD17B10TSHR
SCHEMBL12307473 0.85 PLAU (0.42) ALDH1A1KDM4EMEN1KMT2AGAA
SCHEMBL12307478 0.83 GRM5 (0.40) ALDH1A1KDM4EMEN1KMT2AGRM5
SCHEMBL12307462 0.83 GRM5 (0.38) KDM4EGRM5
SCHEMBL12307444 0.83 ALDH1A1 (0.41) ALDH1A1KDM4EGRM5POLB
SCHEMBL12335625 0.83 HPGD (0.42) ENPP3ALPLXIAPGRM5NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 — — US disclosed
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230472-A1 RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY PIK3R5, PIK3R4, PIK3R1 ALDH1A1 3559/4885NPSR1 4700/4885KDM4E 1658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback